- Lifespot Health (LSH) has appointed Matthew Golden as CEO effective immediately
- Matthew is a commercial healthcare professional with almost 20 years experience in the pharmaceutical industry both in Australia and overseas
- He has worked with the likes of Medical Developments International where he drove the sales of the ‘Green Whistle’ used in pain relief
- At Lifespot, Matthew will review the company’s telehealth and medical cannabis inhaler strategies, and define the timing of its Medihale clinical trial
- Additionally, Rodney Harrington and Frank Cannavo will resume their respective roles of Non-Executive Chairman and Non-Executive Director
- Lifespot is up 17.7 per cent on the back of this news with shares trading for six cents each
